Chinese teen narrowly escapes death after eating only vegetables and laxatives to fit into birthday dress
(Also read: Chinese man helps revive collapsed woman with CPR, faces groping allegations online)
Collapsed after weeks of extreme dieting
The teenager, identified as Mei, was rushed to hospital in a critical condition after she suddenly lost strength in her limbs and experienced severe shortness of breath. Her condition deteriorated rapidly, prompting an emergency 12-hour medical intervention to save her life.
According to the Xiaoxiang Morning Herald, cited by SCMP, Mei had been subsisting solely on a minimal quantity of vegetables and laxatives for two weeks. Medical examinations revealed that her blood potassium levels had plummeted to dangerously low levels, leading to a serious condition known as hypokalaemia.
Life-threatening effects of poor nutrition
Dr Peng Min, who treated Mei at Hunan People's Hospital, explained that 'serious hypokalaemia can cause respiratory failure and sudden cardiac arrest.' He stressed that the body's potassium levels are vital for muscle and nerve function, and drastic imbalances can be fatal.
Another doctor from a separate Hunan hospital, surnamed Li, said such potassium depletion is often triggered by unbalanced diets and dehydration. 'It's important to maintain a healthy intake of essential nutrients,' he added.
Dr Peng further advised that to maintain proper potassium levels, people should consume foods like bananas, chicken, and potatoes, and ensure they stay well-hydrated.
(Also read: Chinese university student gives birth to 4.5 kg baby in dormitory while preparing for final exam)
Mei vows never to repeat the mistake
As per the SCMP report, Mei has now made a full recovery and was recently discharged from hospital. She reportedly expressed deep regret over her actions and promised never to resort to extreme dieting methods again.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Mint
28 minutes ago
- Mint
India-UK FTA to boost bilateral trade for pharma, medtech, say industry bodies
The India-UK free trade agreement, signed on Thursday, is expected to open up new opportunities for Indian pharmaceutical and medical device makers. The deal is also expected to improve access to medical devices from the UK in India. Medical device manufacturers anticipate an increase in trade between the two countries but are awaiting clarity on non-tariff measures and on whether regulatory processes will be streamlined. 'Previously, medical devices imported into the UK were duty-free, so tariff restrictions were not an issue but regulatory approval costs and time were a challenge,' said Rajiv Nath, forum coordinator of industry body Association of Indian Medical Device Industry (Aimed). The body had previously sought recognition of regulatory approvals from the CDSCO or the Quality Council of India's voluntary Indian Certification for medical devices to fast-track approvals by the UK's Medicines and Healthcare products Regulatory Agency (MHRA). 'We look forward to an update on this,' said Nath. However, medtech manufacturers are also seeking strict monitoring of imports to India, to prevent other countries rerouting products into India through the UK. Mint had previously reported that domestic manufacturers raised concerns over the possibility of Chinese-origin products being routed through the UK to exploit the zero-tariff provisions under the FTA. India levies about 7.5% import duties on medical devices from the UK, which are expected to come down in a phased manner after the deal, Nath said. In 2024, medical device exports to the UK increased by 13% year-on-year to ₹ 1,015 crore, while imports from the UK rose 36% to ₹ 2,295 crore, according to Exim data. 'It not only strengthens trade ties but also opens new avenues for advanced technology collaborations between Indian and UK companies,' Himanshu Baid, managing director of Poly Medicure Ltd, said in a statement. 'With India exporting medical devices worth approximately $115 million to the UK, one of our top 10 export destinations, this agreement is poised to further boost our presence,' he added. The trade deal is also expected to open up the market for India's generic drugmakers. 'As per the indications, the pharma sector will have opportunities to supply affordable and quality assured medicine contributing to better patient care in the UK,' said Sudarshan Jain, secretary general of the Indian Pharmaceutical Alliance (IPA). 'We are awaiting further details to identify specific areas where these opportunities can be effectively leveraged,' he added. Generic players like Lupin, Biocon, Dr. Reddy's Laboratories and Wockhardt, which have exposure to the UK market, could stand to benefit.
NDTV
3 hours ago
- NDTV
Chinese Man Spends Rs 5 Crore On Detox At Hair Salon, Ends Up In Pain With No Refund
A man in China has revealed that he spent over approximately $600,000 (Rs 5 Crore) at a hair salon over two years on unlicensed detox and wellness treatments, according to The South China Morning Post. These included enemas, acupuncture, and massages, which allegedly led to health problems. The man, surnamed Cheng, from Hefei in Anhui province, met a salon manager in April 2023 who invited him to a new branch opening. There, another manager persuaded him to try a massage and pushed him into purchasing beauty services through an account top-up system. Cheng claims he was repeatedly pressured to top up his account during future visits. He later experienced physical pain from the treatments and was denied a refund by the salon, sparking widespread attention online. "They were all young boys and girls, kneeling and saying they were poor and couldn't even afford rent, relying on customers to help support their parents. Older beauticians nearby would consistently urge customers to top up, stating that the staff earned commissions based on performance," Cheng told SCMP. Over two years, Cheng spent more than 4.3 million yuan on various "wellness" services, including treatments like "skin-breaking needle detox" and multiple enema sessions marketed as "bowel cleansing." He noted that a single course of enema treatment alone cost around 300,000 yuan (US$42,000). Other services comprised massages priced at 500-600 yuan per body area and "belly dampness removal" sessions, which ranged from 1,000 to 2,000 yuan each. Records indicate that one top-up in January alone totalled 388,000 yuan (US$54,000), and by March 30, his account balance exceeded 1.7 million yuan. Cheng underwent treatments at a salon promising weight loss and youthful appearance. However, he experienced health issues, including diarrhea and unhealed needle marks. When he discovered the salon lacked medical qualifications, he requested a refund but was denied. Cheng reported the incident to authorities, and an investigation was launched into the salon's alleged unlicensed medical practices.
Time of India
7 hours ago
- Time of India
India-UK FTA: Zero duty to boost India's generic drug, medical device exports to Britain
Exports of generic medicines and medical devices like X-ray systems and surgical instruments will get a boost as Britian has agreed upon zero duty under the free trade agreement. The trade agreement between India and the UK was singed on Thursday in London in the presence of Prime Minister Narendra Modi and UK premier Keir Starmer. Explore courses from Top Institutes in Please select course: Select a Course Category Finance Design Thinking Degree others PGDM Leadership Operations Management Artificial Intelligence Management Data Science Product Management Digital Marketing MCA Cybersecurity Others healthcare Public Policy CXO Project Management Healthcare MBA Data Science Skills you'll gain: Duration: 9 Months IIM Calcutta SEPO - IIMC CFO India Starts on undefined Get Details Skills you'll gain: Duration: 7 Months S P Jain Institute of Management and Research CERT-SPJIMR Fintech & Blockchain India Starts on undefined Get Details Skills you'll gain: Duration: 9 Months IIM Calcutta SEPO - IIMC CFO India Starts on undefined Get Details Skills you'll gain: Duration: 9 Months IIM Calcutta SEPO - IIMC CFO India Starts on undefined Get Details Skills you'll gain: Duration: 7 Months S P Jain Institute of Management and Research CERT-SPJIMR Fintech & Blockchain India Starts on undefined Get Details "Significant share of medical devices like surgical instruments, diagnostic equipments, ECG machines, X-Ray systems will not attract any duty," PTI reported quoting a commerce ministry official. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Cardiologist: The Best Method for a Flat Stomach After 50 (It's Genius!) Lulutox Undo The deal will reduce costs for Indian med-tech companies and make products more competitive in the UK market. "Given the UK's shift away from reliance on Chinese imports post-Brexit and COVID-19, Indian manufacturers are poised to emerge as a favoured, cost-effective alternative, especially with zero-duty pricing for medical devices," the official told PTI. Live Events The commerce ministry has said that zero tariff provisions under the FTA are expected to significantly enhance the competitiveness of Indian generics in the UK market, which remains India's largest pharmaceutical export destination in Europe. Currently, India exports $23.31 billion globally and the UK imports nearly $30 billion, but Indian pharma accounts for under $1 billion, indicating significant headroom for growth. The pharma sector has only 56 tariff lines, which is just 0.6 per cent of the total, the document stated. Despite the small representation, pharmaceutical sector holds high value and strategic importance, especially in global trade, the document stated. India's pharmaceutical industry is the world's third largest by volume and 14th largest in terms of value. The sector's exports rose 10 per cent year-on-year to $30.5 billion in FY 2024-25. The industry is leading in the manufacture of high-quality generic drugs at competitive prices over the last 30 years. India is the largest supplier of generic medicines with a 20 per cent share in the global supply by manufacturing 60,000 different generic brands across 60 therapeutic categories. Indian products are shipped to over 200 countries around the globe, with Japan, Australia, West Europe and the US as the main destinations. The current market size of the medical devices sector in India is estimated to be $11 billion and expected to reach $50 billion by 2030.
